SCHEMBL11956457

SCHEMBL11956457

COC(=O)C1C(N)C2C=CC1C1CC21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ GLA P06280 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ PKM P14618 1/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ TP53 P04637 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MMP2 P08253 1/20 0.33
▸ ANPEP P15144 1/20 0.33
▸ PPM1B O75688 1/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ PPP1CC P36873 1/20 0.33
▸ CYP1A2 P05177 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8760765 0.80 POLB (0.70) POLBTDP1ALDH1A1HTTGLA
SCHEMBL393414 0.80 POLB (0.70) POLBTDP1ALDH1A1HTTGLA
SCHEMBL389507 0.80 POLB (0.70) POLBTDP1ALDH1A1HTTGLA
SCHEMBL3200631 0.80 POLB (0.70) POLBTDP1ALDH1A1HTTGLA
SCHEMBL3215221 0.80 POLB (0.70) POLBTDP1ALDH1A1HTTGLA
SCHEMBL21943782 0.74 ALDH1A1 (0.46) POLBTDP1ALDH1A1HTTGLA
SCHEMBL11263569 0.71 CYP2C19 (0.41) POLBALDH1A1HTTGLAHPGD
SCHEMBL12732732 0.71 PPM1B (0.43) POLBALDH1A1HTTGLAHPGD
SCHEMBL24516552 0.70 ALDH1A1 (0.43) POLBALDH1A1HTTPKMSMN1; SMN2
SCHEMBL17790447 0.70 ALDH1A1 (0.43) POLBALDH1A1HTTPKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120302744-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2012-11-29 — — US disclosed
US-20120302744-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS ANADYS PHARMACEUTICALS, INC. (US) 2012-11-29 — — US disclosed
US-8236948-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2012-08-07 — — US disclosed
US-8236948-B2 5,6-dihydro-1H-pyridin-2-one compounds ANADYS PHARMACEUTICALS, INC. (US) 2012-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302744-A1 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS DPYD, NQO1, MT-ND5 POLB 1532/4885TDP1 1353/4885ALDH1A1 205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback